MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-004.03|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISOSFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617PID|1||P12345887^^^EHRSy&2.16.840.1.113883.3.62.5.27&ISO^MR||Hisan^Toyoto^^^^^L||19870517|M||2028-9^Asian^CDCREC^A^Asian^L|1201 Bears Ave^^Tampa^FL^33606^USA^H^^12057||^PRN^PH^^^407^2444554|||||||||N^Not Hispanic or Latino^HL70189ORC|RE|ORD2113586-3^^2.16.840.1.113883.3.62.5.27^ISO|TEST0001^LIS^2.16.840.1.113883.3.72.6.27^ISO|||||||||125627^Bucci^Tampa^^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI||^WPN^PH^^^407^3031200|||||||Tampa General Hospital|1 Tampa General Circle^^Tampa^FL^33606^USA^L|^WPN^PH^^^407^3031200|555 Orange Ave^^Maitland^FL^33606^^OOBR|1|ORD2113586-3^^2.16.840.1.113883.3.62.5.27^ISO|TEST0001^LIS^2.16.840.1.113883.3.72.6.27^ISO|6463-4^Bacteria identified in Unspecified specimen by Culture^LN^75400008^CULTURE, BLOOD^L^2.40|||20120612|||||||||125627^Bucci^Tampa^^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI|^WPN^PH^^^407^3031200|||||201206170842-0500|||FOBX|1|CWE|6463-4^Bacteria identified in Unspecified specimen by Culture^LN^75400008^CULTURE, BLOOD^L^2.40||9861002^Streptococcus pneumoniae (organism)^SCT^^^^07/31/2012^^Streptococcus pneumoniae||||||F|||20120612|||||20120616||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MDSPM|1|^s201206-34598-1&&2.16.840.1.113883.3.72.10.9&ISO||119297000^Blood specimen (specimen)^SCT^BLD^Blood^L^07/31/2012|||||||||||||20120612|20120612OBR|2||TEST000123B^LIS^2.16.840.1.113883.3.72.6.27^ISO|50545-3^Bacterial Susceptibility Panel in Isolate by Minimum Inhibitory Concentration (MIC)^LN^85400007^SUSCEPTIBILITY PANEL, MIC^L^2.40|||20120612|||||||||125627^Bucci^Tampa^^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI|^WPN^PH^^^407^3031200|||||201206170842-0500|||F|6463-4&Bacteria identified in Unspecified specimen by Culture&LN&75400008&CULTURE, BLOOD&L^^Streptococcus pneumoniae (organism)|||^TEST0001&LIS&2.16.840.1.113883.3.72.6.27&ISOOBX|1|SN|20-8^Amoxicillin + Clavulanate [Susceptibility] by Minimum Inhibitory concentration (MIC)^LN^AUG^AMOX/CLAVULANATE^L^2.40||<^2|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||S^Susceptible^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MDOBX|2|SN|141-2^Ceftriaxone [Susceptibility] by Minimum Inhibitory concentration (MIC)^LN^CAX^CEFTRIAXONE^L^2.40||^2|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||S^Susceptible^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MDOBX|3|SN|193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^CC^CLINDAMYCIN^L^2.40||^4|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||S^Susceptible^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MDOBX|4|SN|108-1^Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^CTX^CEFOTAXIME^L^2.40||^2|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||S^Susceptible^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MDOBX|5|SN|145-3^Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^CXMP^CEFUROXIME, SODIUM^L^2.40||>^32|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||R^Resistant^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MDOBX|6|SN|233-7^Erythromycin  [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^E^RYTHROMYCIN^L^2.40||>^32|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||R^Resistant^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MDOBX|7|SN|6644-9^Cefepime [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^FEP^CEFEPIME^L^2.40||^4|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||S^Susceptible^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MDOBX|8|SN|20396-8^Levofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^LVX^LEVOFLOXACIN^L^2.40||<^2|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||S^Susceptible^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MDOBX|9|SN|6652-2^Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^MEM^MEROPENEM^L^2.40||^4|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||S^Susceptible^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MDOBX|10|SN|6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^PEN^Penicillin^L^2.40||>^32|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||R^Resistant^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MDOBX|11|SN|524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^VA^VANCOMYCIN^L^2.40||^2|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||S^Susceptible^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD